IPAM

Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder

Pharmaceutical drug development services; clinical research and development of medicines; scientific study and research in the field of medicine; scientific research in the nature of evaluating clinical trials; providing laboratory research services in the field of biology; research and development in the pharmaceutical and biotechnology fields

Genetic testing for medical research and treatment purposes; providing gene therapy for medical treatment purposes; medical diagnostic testing, monitoring and reporting services